Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Futura reports promising topline results from pivotal study of MED-2002 for erectile dysfunction

Sep. 7, 2016

FDA clears IND for phase I trial of Trappsol Cyclo

Sep. 7, 2016

Arrowhead Pharmaceuticals begins phase II study of ARC-AAT

Sep. 7, 2016

University of Southern California team reveals growth hormone receptor antagonists

Sep. 6, 2016

Lilly prepares and tests MetAP 2 and DPP IV inhibitors

Sep. 6, 2016

New class of FBPase 1 inhibitors identified at Chinese Academy of Medical Sciences

Sep. 5, 2016

Guangzhou Institutes of Biomedicine and Health divulges UCP 1 activators

Sep. 5, 2016

FDA extends IDegLira NDA review

Sep. 5, 2016

Glucox Biotech describes novel NADPH oxidase 4 inhibitors

Sep. 5, 2016

Merck & Co. discontinues development of odanacatib for osteoporosis

Sep. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...